Browse > Article
http://dx.doi.org/10.3746/jfn.2004.9.1.071

The Combined Effect of β2- and β3-Adrenergic Receptor Genotypes on Hyperglycemic Risk in the Korean Population  

Oh, Hyun-Hee (Department of Medical R&D, Korea Institute of Oriental Medicine)
Kim, Kil-Soo (Kirin Oriental Hospita)
Park, Sun-Mi (Department of Medical R&D, Korea Institute of Oriental Medicin)
Shin, Seung-Uoo (Kirin Oriental Hospita)
Yang, Hun-Sung (Department of Medical R&D, Korea Institute of Oriental Medicin)
Yoon, Yoo-Sik (Department of Medical R&D, Korea Institute of Oriental Medicine)
Publication Information
Preventive Nutrition and Food Science / v.9, no.1, 2004 , pp. 71-78 More about this Journal
Abstract
Adrenergic receptors play a major role in thermogenesis and lipolysis in brown and visceral adipose tissues, and have been implicated in the pathogenesis of obesity and metabolic disorders. The purpose of this study was to estimate the effects of $\beta$2-adrenergic receptor ($\beta$2AR) and $\beta$3-adrenergic receptor ($\beta$3AR) genotypes on hyperglycemia and obesity in the Korean population. A representative sample consisting of 530 Korean men and women were measured for height, weight, BMI, WHR, obesity index and body composition. The genotypes of $\beta$2AR polymorphism in codon 27 and $\beta$3AR polymorphism in codon 64 were analyzed by the PCR RFLP method. Serum concentrations of fasting glucose, total cholesterol, HDL cholesterol and triglyceride were determined. The frequencies of $\beta$2AR and $\beta$3AR genotype were: both wild type, 62.5% ; only $\beta$2AR variant type, 12.8% ; only $\beta$3AR variant type, 18.8% ; and both variant type, 5.8% ; the frequency of E and R alleles were 0.098 and 0.137, respectively. Among the physiological parameters, fasting glucose level was significantly higher in subjects with both variant type compared with the three other types (p <0.05), Subjects with both variant type had 12%, 12% and 9.3% increases in serum glucose levels compared with wild type, only $\beta$2AR variant type, and only $\beta$3AR variant type, respectively. When logistic regression analysis was conducted to estimate the risk for hyperglycemia, the subjects were selected for fasting blood glucose concentrations of more than 6.105 m㏖/L (110 mg/dL), and the odds ratios were 1.215 (p=0.636) for only $\beta$2AR variant type,1.659 (p=0.089) for only $\beta$3AR variant type, and 3.078 (p=0.011) for both variant type. These results suggest that the interaction of $\beta$2AR and $\beta$3AR variant genotypes has a strong association with increased glucose levels, and might be a significant risk factor for hyperglycemia among Korean subjects.
Keywords
$\beta$2-adrenergic receptor; $\beta$3-adrenergic receptor; polymorphism; hyperglycemia; obesity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 An adoption study of human obesity /
[ Stunkard AJ;Sorensen TI;Hanis C;Teasdale TW;Chakraborty R;Schull WJ;Schulsinger F ] / N Engl J Med   DOI   ScienceOn
2 Genetics of obesity /
[ Bouchard C;Perusse L ] / Annu Rev Nutr   DOI   ScienceOn
3 Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns /
[ Sipilainen R;Uusitupa M;Heikkinen S;Rissanen A;Laakso M ] / Diabetes   DOI   ScienceOn
4 The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins /
[ Ehrenborg E;Skogsberg J;Ruotolo G;Large V;Eriksson P;Arner P;Hamsten A ] / J Intern Med   DOI   ScienceOn
5 Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain /
[ Fujisawa T;Ikegami H;Yamato E;Takekawa K;Nakagawa Y;Hamada Y;Oga T;Ueda H;Shintani M;Fukuda M;Ogihara T ] / Diabetologia   DOI   ScienceOn
6 In situ assessment of the role of the beta 1-, beta 2- and beta 3- adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue /
[ Barbe P;Millet L;Galitzky J;Lafontan M;Berlan M ] / Br J Pharmacol   DOI   ScienceOn
7 Relation of body fat distribution to metabolic complications of obesity /
[ Kissebah AH;Vydelingum N;Murray R;Evans DJ;Hartz AJ;Kalkhoff RK;Adams PW ] / J Clin Endocrinol Metab   DOI
8 Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity /
[ Fujioka S;Matsuzawa Y;Tokunaga K;Tarui S ] / Metabolism   DOI   ScienceOn
9 Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity /
[ Clement K;Vaisse C;Manning BS;Basdevant A;Guy Grand B;Ruiz J;Silver KD;Shuldiner AR;Froguel P;Strosberg AD ] / N Engl J Med   DOI   ScienceOn
10 Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta3-adrenergic receptor gene /
[ Urhammer SA;Clausen JO;Hansen T;Pedersen O ] / Diabetes   DOI   ScienceOn
11 Lack of beta3-adrenergic effect on lipolysis in human subcutaneous adipose tissue /
[ Rosenbaum M;Malbon CC;Hirsch J;Leibel RL ] / J Clin Endocrinol Metab   DOI   ScienceOn
12 The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men /
[ Mori Y;Kim Motoyama H;Ito Y;Katakura T;Yasuda K;Ishiyama Shigemoto S;Yamada K;Akanuma Y;Ohashi Y;Kimura S;Yazaki Y;Kadowaki T ] / Biochem Biophys Res Commun   DOI   ScienceOn
13 Trp64Arg beta3-adrenergic receptor and obesity in Mexican Americans /
[ Silver K;Mitchell BD;Walston J;Sorkin JD;Stern MP;Roth J;Shuldiner AR ] / Hum Genet   DOI   ScienceOn
14 Role of the beta3-adrenergic receptor locus in obesity and non insulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair /
[ Elbein S.;Hoffman M;Barrett K;Wegner K;Miles C;Bachman K;Berkowitz D;Shuldiner AR;Leppert MF;Hasstedt S ] / J Clin Endocrinol Metab   DOI   ScienceOn
15 The W64R variant of the beta3-adrenergic receptor is not associated with type Ⅱ diabetes or obesity in a large Finnish sample /
[ Ghosh S;Langefeld CD;Ally D;Watanabe RM;Hauser ER;Magnuson VL;Nylund SJ;Valle T;Eriksson J;Bergman RN;Tuomilehto J;Collins FS;Boehnke M ] / Diabetologia   DOI   ScienceOn
16 Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects /
[ Kim SH;Kim DJ;Seo IA.;Min YK;Lee MS;Kim KW;Lee MK ] / Metabolism   DOI   ScienceOn
17 Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertrigly ceridaemia, and diabetes mellitus /
[ Ishiyama-Shigemoto S;Yamada K;Yuan X;Ichikawa F;Nonaka K ] / Diabetologia   DOI   ScienceOn
18 The Trp64Arg mutation of the beta 3 adrenergic receptor gene has no effect of obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts /
[ Gagnon J;Mauriege P;Roy S;Sjostrom D;Chagnon YC;Dionne FT;Oppert JM;Perusse L;Sjostrom L;Bouchard C ] / J Clin Invest   DOI   ScienceOn
19 Report of the expert committee on the diagnosis and classification of diabetes mellitus /
[] / Diabetes Care   DOI
20 Comparative analysis of obesity by beta-2, 3 adrenergic receptor gene polymorphism in Korean young females /
[ Hong JM;Ahn HS;Kim JH;Park YS;Choi SM;Yoon YS ] / Korean J Nutr
21 Human beta -2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function /
[ Large V;Hellstrom L;Reynisdottir S;Lonnqvist F;Eriksson P;Lannfelt L;Arner P ] / J lin Invest   DOI   ScienceOn
22 Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistane syndrome /
[ Sakane N;Yoshida T;Umekawa,T;Kondo M;Sakai Y;Takahashi T ] / Diabetologia   DOI   ScienceOn
23 The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population based Caucasian cohort /
[ Buettner R;Schaffler A;Arndt H;Rogler G;Nusser J;Zietz B;Enger I;Hugl S;Cuk A;Scholmerich J;Palitzsch KD ] / J Clin Endocrinol Metab   DOI   ScienceOn
24 Sigificance of β3-adrenergic receptor gene polymorphism in the pathogenesis of NIDDM in Koreans /
[ Ahn KJ;Kim KA.;Kim YS;Choung JH;Koh EM;Min YK;Lee MS;Lee MK;Kim JW;Kim KW ] / Kor Assoc Inter Medicine
25 Association of the Trp64Arg mutation of the beta3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects /
[ Shima Y;Tsukada T;Nakanishi K;Ohta H ] / Clin Chim Acta   DOI   ScienceOn
26 A mutation in the beta3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects /
[ Kadowaki H;Yasuda K;Iwamoto K;Otabe S;Shimokawa K;Silver K;Walston J;Yoshinaga H;Kosaka K;Yamada N ] / Biochem Biophys Res Commun   DOI   ScienceOn
27 The significance of the Trp 64 Arg mutation of the beta 3 adrenergic receptor gene in impaired glucose tolerance, non-insulin dependent diabetes mellitus, and insulin resistance in Japanese subjects /
[ Azuma N;Yoshimasa Y;Nishimura H;Yamamoto Y;Masuzaki H;Suga J;Shigemoto M;Matsuoka N;Tanaka T;Satoh N;Igaki T;Miyamoto Y;Itoh H;Yoshimasa T;Hosoda K;Nish S;Kakao K ] / Metabolism   DOI   ScienceOn
28 The Trp64Arg mutation of the beta3-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women /
[ McFarlane-Anderson N;Bennett F;Wilks R;Howell S;Newsome C;Cruickshank K;Forrester T ] / Metabolism   DOI   ScienceOn
29 Relation of beta3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais /
[ Ongphiphadhanakul B;Rajatanavin R;Chanprasertyothin S;Piaseu N;Chailurkit L;Komindr S;Bunnag P;Puavilai G ] / Metabolism   DOI   ScienceOn
30 Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients /
[ Sakane N;Yoshida T;Umekawa T;Kogure A;Takakura Y;Kondo M ] / Diabetes Care   DOI   ScienceOn
31 Association of beta3-adrenergic receptor gene polymorphism with insulin resistance in Japanese-American men /
[ Kawamura T;Egusa G;Okubo M;Imazu M;Yamakido M ] / Metabolism   DOI   ScienceOn
32 Beta 3-adrenergic receptor gene variant and lipid metabolism in Pima Indians /
[ Tataranni PA;Pratley R;Shuldiner A;Ravussin E ] / Diabetologia   DOI   ScienceOn
33 The Trp64Arg polymorphism of the beta 3-Adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome /
[ Rissanen J;Kuopusjarvi J;Pihlajamaki J;Sipilainen R;Heikkinen S;Vanhala M;Kekalainen P;Kuusisto J;Laakso M ] / Diabetes Care   DOI   ScienceOn
34 No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue /
[ Snitker S;Odeleye OE;Hellmer J;Boschmann M;Monroe MB;Shuldiner AR;Ravussin E ] / Diabetologia   DOI   ScienceOn
35 Clinical features associated with the homozygous Trp64Arg mutation of the beta3 adrenergic receptor: no evidence for its association with obesity in Japanese /
[ Sun L;Ishibashi S;Osuga J;Harada K;Ohashi K;Gotoda T;Fukuo Y;Yazaki Y;Yamada N ] / Arterioscler Thromb Vasc Biol   DOI   ScienceOn
36 Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic receptor gene /
[ Walston J;Silver K;Bogardus C;Knowler W;Celi FS;Austin S;Manning B;Strosberg AD;Stern MP;Raben N ] / N Engl J Med   DOI   ScienceOn
37 A mutation of the beta3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride /
[ Kim-Motoyama H;Yasuda K;Yamaguchi T;Yamada N;Katakura T;Shuldiner AR;Akanuma Y;Ohashi Y;Yazaki Y;Kadowaki T ] / Diabetologia   DOI   ScienceOn
38 Identifiation of an interactive effect of beta3-and alpha2b-adrenoceptor gene polymorphisms on fat mass in Caucasian women /
[ Dionne IJ;Turner AN;Tchernof A;Pollin TI;Avrithi D;Gray D;Shuldiner AR;Poehlman ET ] / Diabetes   DOI   ScienceOn
39 Association of a polymorphism in the beta3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns /
[ Widen E;Lehto M;Kanninen T;Walston J;Shuldiner AR;Groop LC ] / N Engl J Med   DOI   ScienceOn
40 The different effects of a Gln27Glu beta2-adrenoceptor gene polymorphism on obestiy in males and in females /
[ Hellstrom L;Large V;Reynisdottir S;Wahrenberg H;Arner P ] / J Intern Med   DOI   ScienceOn